Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03621553 · ClinicalTrials.gov registry record · Phase 4
Vitamin D Homeostasis in Sarcoidosis
A Phase 4 study of Sarcoidosis and Vitamin D Insufficiency, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT03621553 is a Phase 4 study of Sarcoidosis and Vitamin D Insufficiency that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 90 participants, below the 2,165-participant average among 21 other Sarcoidosis trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03621553, a Phase 4 study of Sarcoidosis and Vitamin D Insufficiency, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the relationship between vitamin-D status and severity of sarcoidosis, and the effects of vitamin-D repletion in vitamin-D insufficient patients with sarcoidosis. Half the patients with sarcoidosis who are vitamin-D insufficient will receive standard vitamin-D supplementation via standard regimen while the other half will receive a placebo. Sarcoidosis patients who are vitamin-D sufficient will also act as controls.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Ergocalciferol
- DRUG Calcium Citrate with Vitamin D2
Study Locations (1)
Texas
- University of Texas Southwestern Medical Center, and Parkland Health and Hospital System - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2010-07-01 |
| Est. Completion | 2026-12-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03621553
The ClinicalTrials.gov registry entry for NCT03621553 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,165-participant average among 21 other Sarcoidosis trials with a reported enrollment target (96% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Sarcoidosis appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT03621553 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03621553 about?
NCT03621553 is a clinical study titled "Vitamin D Homeostasis in Sarcoidosis". This study evaluates the relationship between vitamin-D status and severity of sarcoidosis, and the effects of vitamin-D repletion in vitamin-D insufficient patients with sarcoidosis. Half the patients with sarcoidosis who are vitamin-D insufficient will receive standard vitamin-D supplementation vi...
What is the current status of trial NCT03621553?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2010-07-01. Estimated completion is 2026-12-30.
What conditions does trial NCT03621553 study?
This clinical trial studies the following conditions: Sarcoidosis, Vitamin D Insufficiency.
What interventions are being tested in trial NCT03621553?
The interventions under investigation include: Placebo (DRUG), Ergocalciferol (DRUG), Calcium Citrate with Vitamin D2 (DRUG).
Who is sponsoring clinical trial NCT03621553?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03621553 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcoidosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Use of CXCL9 as a Biomarker of Acthar Efficacy
RECRUITING · Phase 4
-
Inhaled Iloprost for Sarcoidosis-associated Pulmonary Hypertension
COMPLETED · Phase 4
-
Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
RECRUITING
-
Cardiovascular Multimodality Imaging Study
RECRUITING
-
Cardiac Sarcoidosis Randomized Trial
RECRUITING · Phase 3
-
Interstitial Lung Disease Research Unit Biobank
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.